文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

前列腺癌IMPT、VMAT与4π放疗计划比较

Treatment planning comparison of IMPT, VMAT and 4π radiotherapy for prostate cases.
PubMed 文献 · Radiat Oncol · 2017-01-11

本研究对10例前列腺癌患者分别设计IMPT、VMAT与4π计划,处方总剂量79.2 Gy。结果显示IMPT在CTV均匀性和危及器官最大点剂量(股骨头除外)上优于VMAT与4π,但直肠和膀胱中高剂量体积劣于4π,低剂量溢出和积分剂量显著降低。

要点

  • IMPT的CTV均匀性和危及器官最大点剂量优于VMAT与4π,但股骨头剂量更高。
  • 4π在直肠前壁平均剂量及直肠V40至V75上优于IMPT。
  • IMPT低剂量溢出和积分剂量显著降低,与长期生存患者二次癌症风险相关。

核心结论

  • IMPT计划在CTV均匀性和危及器官最大点剂量上优于VMAT和4π计划,但股骨头剂量更高。
  • IMPT在直肠和膀胱中高剂量体积上劣于VMAT和4π,尤其劣于4π,但低剂量溢出和积分剂量显著降低。

研究设计与样本

  • 研究纳入10例前列腺癌患者,分别设计IMPT(带稳健优化)、VMAT和4π计划。
  • 处方初始剂量54 Gy至CTV(涵盖前列腺和精囊),随后前列腺推量25.2 Gy,总剂量79.2 Gy。

主要发现

  • 与IMPT相比,4π降低直肠前壁平均剂量以及直肠V40、V45、V60、V65、V70和V75。
  • IMPT因对穿束布置导致股骨头剂量显著更高(p < 0.05)。
  • IMPT计划膀胱、直肠和直肠前壁最大剂量显著更低。
  • IMPT剂量均匀性显著优于4π和VMAT。

关键数值与推荐

  • 评估指标包括CTV剂量、膀胱和直肠剂量体积(V40、V45、V60、V65、V70、V75、V80)、R100、R50、R10以及CTV均匀性指数(D95/D5)。
  • IMPT计划采用两条共面斜扫描束,位于侧束位置后10°,并考虑射程不确定度。
  • VMAT计划使用两个全共面弧以确保足够PTV覆盖。
  • 4π计划通过贪婪列生成算法从1162个候选非共面束中逆向选择和优化30个束。

临床怎么用

  • 对于期望长期生存的前列腺癌患者,IMPT可降低低剂量溢出和积分剂量,可能减少二次癌症风险。
  • 选择IMPT时需注意股骨头剂量较高以及直肠和膀胱中高剂量体积可能劣于4π。
  • 4π计划在直肠中高剂量体积上具有优势,可作为IMPT的补充或替代选择之一。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Intensity-modulated proton therapy (IMPT), non-coplanar 4π intensity-modulated radiation therapy (IMRT), and volumetric-modulated arc therapy (VMAT) represent the most advanced treatment methods based on heavy ion and X-rays, respectively. Here we compare their performance for prostate cancer treatment. METHODS: Ten prostate patients were planned using IMPT with robustness optimization, VMAT, and 4π to an initial dose of 54 Gy to a clinical target volume (CTV) that encompassed the prostate and seminal vesicles, then a boost prescription dose of 25.2 Gy to the prostate for a total dose of 79.2 Gy. The IMPT plans utilized two coplanar, oblique scanning beams 10° posterior of the lateral beam positions. Range uncertainties were taken into consideration in the IMPT plans. VMAT plans used two full, coplanar arcs to ensure sufficient PTV coverage. 4π plans were created by inversely selecting and optimizing 30 beams from 1162 candidate non-coplanar beams using a greedy column generation algorithm. CTV doses, bladder and rectum dose volumes (V40, V45, V60, V65, V70, V75, and V80), R100, R50, R10, and CTV homogeneity index (D95/D5) were evaluated. RESULTS: Compared to IMPT, 4π resulted in lower anterior rectal wall mean dose as well as lower rectum V40, V45, V60, V65, V70, and V75. Due to the opposing beam arrangement, IMPT resulted in significantly (p < 0.05) greater femoral head doses. However, IMPT plans had significantly lower bladder, rectum, and anterior rectal wall max dose. IMPT doses were also significantly more homogeneous than 4π and VMAT doses. CONCLUSION: Compared to the VMAT and 4π plans, IMPT treatment plans are superior in CTV homogeneity and maximum point organ-at-risk (OAR) doses with the exception of femur heads. IMPT is inferior in rectum and bladder volumes receiving intermediate to high doses, particularly to the 4π plans, but significantly reduced low dose spillage and integral dose, which are correlated to secondary cancer for patients with expected long survival. The dosimetric benefits of 4π plans over VMAT are consistent with the previous publication.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Tran A, Zhang J, Woods K, et al. Treatment planning comparison of IMPT, VMAT and 4π radiotherapy for prostate cases. Radiat Oncol. 2017. PMID: 28077128. doi:10.1186/s13014-016-0761-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。